Arathi Mohan

5PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 23, 2026
A phase 2 multicenter trial of rucaparib and nivolumab as maintenance therapy in patients with advanced biliary tract cancer: BilT-02.

|Feb 27, 2026
Mitochondrial targets in IDH1-mutated cholangiocarcinoma.

Camila Carvalho, Fulei Wuchu, Nicole Peterson

|Jul 22, 2024
PARP inhibitor therapy in patients with IDH1 mutated cholangiocarcinoma.

Arathi Mohan, Elit Quingalahua, Valerie Gunchick

|Apr 28, 2023
Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04).

Arathi Mohan, Kent A Griffith, Fulei Wuchu

|Mar 08, 2022
Integrating Medical Genetics Into Precision Oncology Practice in the Veterans Health Administration: The Time Is Now.

Anthony Scott, Arathi Mohan, Sarah Austin

Pageof 1

Frequent Collaborators

3 joint publications

Vaibhav Sahai

2 joint publications

Mark M Zalupski

2 joint publications

Valerie Gunchick

2 joint publications

Kent A Griffith